More Resources

AKZO NOBEL REJECTS CRITICISM OF 2002 FINANCIAL STATEMENTS.

Biotech Financial Reports • August 1, 2003 •
Article Tools
T   |   T
TEXT SIZE:
printPrint
E-MailE-Mail

Add to My Bookmarks

Adds Article to your Entrepreneur Assist Bookmark page.

Akzo Nobel, Arnhem, the Netherlands, has rejected the criticism expressed by "Stichting Onderzoek Bedrijfs Informatie" (SOBI) of the reporting of pension liabilities in the 2002 financial statements. Akzo Nobel's financial statements are prepared in accordance with Dutch accounting standards (Richtlijnen voor de Jaarverslaggeving) and are accompanied by an unqualified auditors" report.

For the recognition of the pension liabilities the company thus follows the internationally frequently applied standard SFAS 87, which also takes future salary increases into account.

Application of this standard resulted in a charge against shareholders' equity of EUR 1.1 billion for the minimum pension liability in the 2002 financial statements. In a summons, SOBI stated that this amount should have been charged against the statement of income. Akzo Nobel rejects that, because Akzo Nobel has, in conformity with section 271.309 of the Richtlijnen voor de Jaarverslaggeving, fully and consistently applied SFAS 87.


COPYRIGHT 2003 Worldwide Videotex Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.


Browse by Journal Name:
Today on Entrepreneur

e-Business & Technology
Franchise News
Business Book Sampler
Starting a Business
Sales & Marketing
Growing a Business
E-mail*:
Zip Code*: